Tech Company Financing Transactions
Freedom Biosciences Funding Round
MBX Capital, PsyMed Ventures and Startup Yale participated in a $10.5 million Seed venture round for Freedom Biosciences. The round was recorded on 8/23/2022.
Transaction Overview
Company Name
Announced On
8/23/2022
Transaction Type
Venture Equity
Amount
$10,500,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to advance its current lead ketamine program as well as further multiple additional exploratory programs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA 94016
USA
San Francisco, CA 94016
USA
Phone
Undisclosed
Website
Email Address
Overview
The company intends to use the funds to advance its current lead ketamine program as well as further multiple additional exploratory programs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dina Burkitbayeva
Chief Scientific Officer
John Krystal
Co-Founder
Hunter Bouchard
Co-Founder
Morgan Springer
Browse more venture capital transactions:
Prev: 8/23/2022: Mural.xyz venture capital transaction
Next: 8/24/2022: Inworld AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs